JCI-accredited partner hospitals

Lung cancer · In the news · Oct 2026

He flew to Shanghai
for his mother’s cancer pill.

Max Doppelt’s mother has a rare lung cancer that spread to her brain. The drug most likely to help, sunvozertinib, had been sold in China since 2023 but not in the US. Here is the story in English, where the drug stands now, and what to check before you travel for cancer care.

Video: Yangtse Evening Post (扬子晚报); source Song Shifeng, editor Dai Zhehan. Music only; English captions translated by PandaTouring from the on-screen Chinese subtitles.

Transcript

What the clip says, in English.

The clip has music only. This is our translation of Yangtse Evening Post’s Chinese subtitles. One line needs an update: the drug did receive FDA approval in July 2025, but it was still not on sale in the US when the story ran.

  1. 0:00

    On October 22, a post by an American man, Max, about getting a drug from abroad sparked debate online.

    10月22日,美国男子马克斯的一篇“跨国求药”的帖子在社交媒体上引发热议

  2. 0:04

    He said his mother was diagnosed with lung cancer three years ago. Despite chemotherapy, immunotherapy and surgery, in December 2024 it spread to her brain, and no effective treatment could be found in the US.

    他表示,他的母亲3年前确诊肺癌,虽经化疗、免疫治疗和手术治疗,但到2024年12月还是转移到脑部。令人绝望的是,在美国找不到有效的治疗办法

  3. 0:08

    A doctor told him about a Chinese targeted drug, sunvozertinib, that could not be bought in the US, so he set off for China to buy it. Nineteen months on, his mother's cancer is largely under control.

    医生表示,中国研发出一种靶向药“舒沃替尼”,但在美国无法买到,于是他立即启程前往中国买药。令人兴奋的是,用药19个月后,母亲的病情已被基本控制住

  4. 0:12

    His story drew wide discussion. Max says he knows of at least 30 Americans who have made the same trip.

    这段亲身经历在网络引起大量讨论。马克斯表示,据他所知已有至少30名美国人像他一样在“跨国求药”

FAQ

Sunvozertinib and China, answered.

What is sunvozertinib?
Sunvozertinib is a once-daily targeted pill from Dizal Pharmaceutical in Shanghai for non-small cell lung cancer with EGFR exon 20 insertion mutations, an uncommon subtype that responds poorly to older EGFR drugs. It was approved in China in 2023 and received FDA accelerated approval in July 2025 under the brand name Zegfrovy.
Can I buy sunvozertinib in the US now?
As of October 2026 it was not yet sold in the US, despite the 2025 approval. AstraZeneca licensed the drug and said it plans US availability by early 2027. Ask your oncologist about expanded access or trials in the meantime; the situation may have changed since this page was written.
Does it work for everyone?
No. Max himself says it seems to help about half the people who take it, and KFF Health News reports another woman he helped found it stopped working after three months. Debbie's 19 months of control also involved radiation and dose changes. It only applies to tumours with an EGFR exon 20 insertion, which needs a genetic test to confirm.
Is it legal to bring cancer medicine back from China?
It depends, and the decision belongs to US Customs and the FDA at the border. Under the FDA's personal importation policy, the agency may allow a patient to bring in a limited supply, generally up to three months, of an unapproved drug for a serious condition when no effective US treatment is available and a US doctor is supervising care. That is discretion, not a right. Check the FDA's personal importation page and talk to your doctor before you travel.
Do I need a prescription to buy it in China?
Yes. Sunvozertinib is a prescription drug in China, so you need a prescription from a doctor licensed there. In practice that means an in-person oncology consultation, bringing your scans, pathology and genetic test report. We can arrange that consultation; we do not buy, sell or ship medicines.
What else can a China trip offer a lung cancer patient?
Many targeted drugs and clinical trials reach China before other markets. A trip can combine a second opinion from a thoracic oncology team at a major cancer hospital, a review of trials you may be eligible for, and imaging if needed. Your home oncologist should stay in charge of your ongoing treatment.

Sources

Where this comes from.

  1. KFF Health News (Arthur Allen), “As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There”, 20 Oct 2026. Read it
  2. The Star, from South China Morning Post reporting, “'Saved my mum's life': Chinese cancer drug on sale in US after Americans travel to buy it”, 24 Oct 2026. Read it
  3. Shanghai Daily (Guo Jiayi), “26 Boxes of Hope: An American Son's Cancer-Drug Mission to Shanghai”, 1 Nov 2026. Read it
  4. Dizal Pharmaceutical (press release via BioSpace), “ZEGFROVY (sunvozertinib) receives FDA accelerated approval for NSCLC with EGFR exon 20 insertion mutations”, 3 Jul 2025. Read it
  5. US Food and Drug Administration, “Personal Importation”, FDA guidance page. Read it

Video: Yangtse Evening Post (扬子晚报); source Song Shifeng, editor Dai Zhehan. Music only; English captions translated by PandaTouring from the on-screen Chinese subtitles.

Wondering if a China trip
could help?

Send us your diagnosis and genetic test report. We’ll tell you honestly whether an oncology visit in China is worth it, and arrange it if it is.

Free quote